Abiopharma

🔍 Baroda Ventures LLC (Executive)

Company: MNTN, Inc. (MNTN)

Report Date: 2026-08-13

Detailed Transactions and Holdings:

• Sold 26,823 shares of Class A Common Stock at $12.53 per share (Direct)
  Date: 2026-08-13 | Code: S | equity_swap_involved: 0 | shares_owned_after: 6,684,275.00 | transaction_form_type: 4 | Footnotes: F1, F3
• Sold 33,617 shares of Class A Common Stock at $12.56 per share (Direct)
  Date: 2026-08-14 | Code: S | equity_swap_involved: 0 | shares_owned_after: 6,650,658.00 | transaction_form_type: 4 | Footnotes: F2, F3

Footnotes:

• F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.50 to $12.63 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
• F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.50 to $12.63 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
• F3: The securities reported herein are held of record by Baroda Ventures LLC. David C. Bohnett is the manager and sole member of Baroda Ventures LLC, and as such, Mr. Bohnett may be deemed to share beneficial ownership of such securities.